N-(Azetidin-3-yl)-2,2,2-trifluoroacetamide hydrochloride, 97%, 5g

2-Amino nicotinic acid ethyl ester, 95.0%, 100g

4-(2-Methylcyclopropyl)pyridine, 5g

(4-(Pyrrolidin-1-yl)phenyl)boronic acid, 95%, 1g

1-(4-BROMO-3-FLUOROPHENYL)ETHAN-1-AMINE HCL, 95%, 100mg

Dipyrazino[2,3-f:2',3'-h]quinoxaline-2,3,6,7,10,11-hexacarbonitrile, 95.0%, 1g

tert-Butyl 4-(phenylsulfonamido)piperidine-1-carboxylate, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,2-dimethylbenzo[d][1,3]dioxol-5-yl)propanoic acid, 97%, 5g

6-Chloropyrimidine-4-carbonitrile, 95.0%, 25g

2-METHOXY-4,6-DIMETHYLBENZOIC ACID, 95.0%, 1g

4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-furan-2-carboxylic acid amide, 95.0%, 250mg

Myristic acid isopropyl ester, min. 92%, extra pure, 1 l, glass packaging

tert-Butyl 6a-hydroxy-3a,4,6,6a-tetrahydropyrrolo[3,4-c]pyrazole-5(1H)-carboxylate, 97%, 1g